Cyrus L. Harmon Ph.D.
Net Worth

Last updated:

What is Cyrus L. Harmon Ph.D. net worth?

The estimated net worth of Dr. Cyrus L. Harmon Ph.D. is at least $12,651,340 as of 11 Dec 2024. He owns shares worth $4,210,411 as insider, has earned $5,808,969 from insider trading and has received compensation worth at least $2,631,960 in Olema Pharmaceuticals, Inc..

What is the salary of Cyrus L. Harmon Ph.D.?

Dr. Cyrus L. Harmon Ph.D. salary is $657,990 per year as Chief Technology Officer & Director in Olema Pharmaceuticals, Inc..

How old is Cyrus L. Harmon Ph.D.?

Dr. Cyrus L. Harmon Ph.D. is 54 years old, born in 1971.

What stocks does Cyrus L. Harmon Ph.D. currently own?

As insider, Dr. Cyrus L. Harmon Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Olema Pharmaceuticals, Inc. (OLMA) Chief Technology Officer & Director 764,140 $5.51 $4,210,411

What does Olema Pharmaceuticals, Inc. do?

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

OLMA logo
OLMA
Olema Pharmaceuticals, Inc.
$5.51

Cyrus L. Harmon Ph.D. insider trading

Olema Pharmaceuticals, Inc.

Dr. Cyrus L. Harmon Ph.D. has made 38 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 179 units of OLMA stock worth $1,681 on 11 Dec 2024.

The largest trade he's ever made was exercising 30,000 units of OLMA stock on 16 Aug 2023. As of 11 Dec 2024 he still owns at least 764,140 units of OLMA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 179 $9.39 $1,681
Sale
Common Stock 7,958 $8.66 $68,916
Sale
Common Stock 934 $15.55 $14,524
Sale
Common Stock 4,066 $15.58 $63,348
Sale
Common Stock 5,000 $12.26 $61,300
Sale
Common Stock 20,000 $10.77 $215,400
Sale
Common Stock 5,000 $12.33 $61,650
Sale
Common Stock 5,000 $10.93 $54,650
Sale
Common Stock 15,000 $9.41 $141,150
Sale
Common Stock 5,000 $10.92 $54,600
Sale
Common Stock 15,000 $9.51 $142,650
Sale
Common Stock 20,000 $10.97 $219,400
Sale
Common Stock 100 $13 $1,300
Sale
Common Stock 24,900 $12.41 $309,009
Sale
Common Stock 5,000 $15.56 $77,800
Sale
Common Stock 25,000 $12.23 $305,750
Sale
Common Stock 2,500 $14.1 $35,250
Sale
Common Stock 22,500 $13.3 $299,250
Sale
Common Stock 25,000 $12.57 $314,250
Sale
Common Stock 3,989 $13.9 $55,447
Sale
Common Stock 4,192 $14.86 $62,293
Sale
Common Stock 5,000 $15.64 $78,200
Sale
Common Stock 25,000 $12.05 $301,250
Sale
Common Stock 25,000 $12.41 $310,250
Sale
Common Stock 10,000 $11.62 $116,200
Sale
Common Stock 15,000 $9.36 $140,400
Sale
Common Stock 30,000 $10.14 $304,200
Sale
Common Stock 10,000 $6.3 $63,000
Sale
Common Stock 5,000 $6.3 $31,475
Sale
Common Stock 5,000 $6.05 $30,225
Sale
Common Stock 400 $24.76 $9,904
Sale
Common Stock 12,000 $28.03 $336,300
Sale
Common Stock 12,000 $26.3 $315,600
Sale
Common Stock 12,000 $24.97 $299,640
Sale
Common Stock 4,123 $25.63 $105,672
Sale
Common Stock 7,877 $24.83 $195,586
Sale
Common Stock 12,000 $25.48 $305,724
Sale
Common Stock 12,000 $25.48 $305,724

Olema Pharmaceuticals key executives

Olema Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: